Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.

NCT06705127 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HR-positive,HER2-negative Breast Cancer

Interventions

DRUG: TORIPALIMAB INJECTION(JS001 )
RADIATION: Stereotactic Body Radiation Therapy (SBRT)

Sponsor

First Affiliated Hospital of Zhejiang University